A 2026 study in Neurology Open Access found higher vitamin D levels in midlife linked to lower toxic tau protein in the brain ...
Two studies mapped the structures of VPS13 proteins associated with neurodegenerative diseases, laying the groundwork for understanding how mutations disrupt cellular lipid transport.
The AlphaFold Core Team’s Disbandment Shake-up The world of protein structure prediction experienced a seismic shift recently as key members of the ...
Frontiers in Biotechnology and Bioengineering is launching a special issue titled – "False Positives and Negative Results in Protein Sciences" within the ...
GSK Relation Therapeutics AI drug discovery deal worth $110 million funds petascale multi-omic cellular perturbation data ...
Dementia, a progressive loss of memory and decline in mental function that can be caused by various neurological conditions, is estimated to affect more than 57 million people worldwide. Identifying ...
Researchers at Rensselaer Polytechnic Institute (RPI) have found that today's leading artificial intelligence tools for ...
James McDonagh discusses how AI and machine learning are transforming drug discovery and safety assessment, enhancing ...
Furthermore, future studies combining time‑resolved multi‑omics and combinatorial genetics could uncover how these proteins coordinate across development, potentially paving the way for precise, ...
Companies aim to improve drug discovery by training AI on one another’s data and generating large, open datasets ...
Proteins carry out most of the work in the cell, and predicting their structure, function and interactions remains one of the ...
A protein called SORLA may act as a powerful defense against the toxic tau tangles involved in Alzheimer’s disease. Mice with extra SORLA had less tau accumulation, less brain atrophy, and healthier ...